US 12102671
Method of vaccination with an attenuated RSV vaccine formulation
granted A61KA61K2039/5254A61K2039/543
Quick answer
US patent 12102671 (Method of vaccination with an attenuated RSV vaccine formulation) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/5254, A61K2039/543, A61K2039/545, A61K2039/55